CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
Org Biomol Chem. 2018 Apr 18;16(15):2776-2786. doi: 10.1039/c8ob00247a.
Targeting quadruplex DNA structures with small molecules is a promising strategy for anti-cancer drug design. Four phenanthroline polyazamacrocycles were studied for their binding affinity, thermal stabilization, inhibitory effect on the activity of helicase towards human telomeric 22AG and oncogene promoter c-MYC G-quadruplexes (G4s), and their ability to inhibit Taq polymerase-mediated DNA extension. The fluorescence resonance energy transfer (FRET) melting assay indicates that the melting temperature increases (ΔTm values) of c-MYC and 22AG G4s are 17.2 and 20.3 °C, respectively, for the ligand [32]phen2N4 followed by [16]phenN4 (11.3 and 15.0 °C, for c-MYC and 22AG, respectively). Competitive FRET assays show that [32]phen2N4 and [16]phenN4 exhibit G4 selectivity over duplex DNA. Different G4s were compared; no considerable selectivity of the ligands for a specific G4 was found. Circular dichroism (CD) confirms the formation of G4 structures and the melting experiments show that [16]phenN4 and [32]phen2N4 are the most stabilizing ligands with a ΔTm of 19.3 °C and 15.1 °C, respectively, at 5 molar equivalents for the c-MYC G4. The fluorescent intercalator displacement (FID) assay also demonstrates that ligand [32]phen2N4 furnishes very low DC50 values (0.87-1.24 μM), indicating high stabilization of c-MYC and 22AG G4s. These results suggest that the hexyl chain in these compounds plays an important role in regulating the stabilization of these G4s. Binding constants, determined by fluorescence titrations, indicate a moderate ligand-G4 binding with KSV between 105 and 106 M-1 in which [16]phenN4 has a slightly higher apparent binding constant for telomeric 22AG G4 than that for the c-MYC G4. The ligand's ability to inhibit Taq polymerase confirms the biological activity of [16]phenN4 and [32]phen2N4 against the c-MYC G4. In addition, ligands [32]phen2N4 and [16]phenN4 affect the unwinding activity of Pif1 in the presence of DNA systems harboring c-MYC and telomeric G4 motifs.
靶向小分子的四重结构是一种有前途的抗癌药物设计策略。研究了四个菲咯啉聚氮杂大环配合物的结合亲和力、热稳定性、对人端粒 22AG 和癌基因启动子 c-MYC G-四链体 (G4) 的螺旋酶活性的抑制作用,以及它们抑制 Taq 聚合酶介导的 DNA 延伸的能力。荧光共振能量转移 (FRET) 熔融测定表明,配体 [32]phen2N4 后 [16]phenN4 使 c-MYC 和 22AG G4 的熔点升高 (ΔTm 值) 分别为 17.2°C 和 20.3°C,分别为 11.3°C 和 15.0°C,用于 c-MYC 和 22AG。竞争性 FRET 测定表明,[32]phen2N4 和 [16]phenN4 对双链 DNA 表现出 G4 选择性。比较了不同的 G4,发现配体对特定 G4 没有明显的选择性。圆二色性 (CD) 证实了 G4 结构的形成,熔融实验表明,[16]phenN4 和 [32]phen2N4 是最稳定的配体,在 5 摩尔当量时,c-MYC G4 的 ΔTm 值分别为 19.3°C 和 15.1°C。荧光嵌入剂置换 (FID) 测定也表明,配体 [32]phen2N4 提供非常低的 DC50 值(0.87-1.24μM),表明 c-MYC 和 22AG G4 高度稳定。这些结果表明,这些化合物中的己基链在调节这些 G4 的稳定性方面发挥了重要作用。荧光滴定法测定的结合常数表明,配体与 G4 的结合具有中等强度,KSV 值在 105 到 106 M-1 之间,其中 [16]phenN4 对端粒 22AG G4 的表观结合常数略高于 c-MYC G4。配体抑制 Taq 聚合酶的能力证实了 [16]phenN4 和 [32]phen2N4 对 c-MYC G4 的生物活性。此外,配体 [32]phen2N4 和 [16]phenN4 影响 Pif1 在含有 c-MYC 和端粒 G4 基序的 DNA 系统中的解旋活性。